Health care infrastructure for financially sustainable clinical genomics
Next-generation sequencing has evolved technically and economically into the method of choice for interrogating the genome in cancer and inherited disorders. The introduction of procedural code sets for whole-exome and genome sequencing is a milestone toward financially sustainable clinical implemen...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 July 2016
|
| In: |
The journal of molecular diagnostics
Year: 2016, Jahrgang: 18, Heft: 5, Pages: 697-706 |
| ISSN: | 1943-7811 |
| DOI: | 10.1016/j.jmoldx.2016.04.003 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1016/j.jmoldx.2016.04.003 Verlag, kostenfrei, Volltext: http://www.sciencedirect.com/science/article/pii/S1525157816300861 
|
| Verfasserangaben: | Jochen K. Lennerz, Heather M. McLaughlin, Jason M. Baron, David Rasmussen, Meini Sumbada Shin, Nancy Berners-Lee, Julie Miller Batten, Kathryn J. Swoboda, Manish K. Gala, Harland S. Winter, Jeremy D. Schmahmann, David A. Sweetser, Marianne Boswell, Maciej Pacula, Albrecht Stenzinger, Long P. Le, William Hynes, Heidi L. Rehm, Anne Klibanski, Stephen W. Black-Schaffer, Jeffrey A. Golden, David N. Louis, Scott T. Weiss, and A. John Iafrate |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1569771324 | ||
| 003 | DE-627 | ||
| 005 | 20240316100322.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180213s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jmoldx.2016.04.003 |2 doi | |
| 035 | |a (DE-627)1569771324 | ||
| 035 | |a (DE-576)49977132X | ||
| 035 | |a (DE-599)BSZ49977132X | ||
| 035 | |a (OCoLC)1340987006 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lennerz, Jochen K. |d 1974- |e VerfasserIn |0 (DE-588)13368038X |0 (DE-627)550687572 |0 (DE-576)300020848 |4 aut | |
| 245 | 1 | 0 | |a Health care infrastructure for financially sustainable clinical genomics |c Jochen K. Lennerz, Heather M. McLaughlin, Jason M. Baron, David Rasmussen, Meini Sumbada Shin, Nancy Berners-Lee, Julie Miller Batten, Kathryn J. Swoboda, Manish K. Gala, Harland S. Winter, Jeremy D. Schmahmann, David A. Sweetser, Marianne Boswell, Maciej Pacula, Albrecht Stenzinger, Long P. Le, William Hynes, Heidi L. Rehm, Anne Klibanski, Stephen W. Black-Schaffer, Jeffrey A. Golden, David N. Louis, Scott T. Weiss, and A. John Iafrate |
| 264 | 1 | |c 25 July 2016 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.02.2018 | ||
| 520 | |a Next-generation sequencing has evolved technically and economically into the method of choice for interrogating the genome in cancer and inherited disorders. The introduction of procedural code sets for whole-exome and genome sequencing is a milestone toward financially sustainable clinical implementation; however, achieving reimbursement is currently a major challenge. As part of a prospective quality-improvement initiative to implement the new code sets, we adopted Agile, a development methodology originally devised in software development. We implemented eight functionally distinct modules (request review, cost estimation, preauthorization, accessioning, prebilling, testing, reporting, and reimbursement consultation) and obtained feedback via an anonymous survey. We managed 50 clinical requests (January to June 2015). The fraction of pursued-to-requested cases (n = 15/50; utilization management fraction, 0.3) aimed for a high rate of preauthorizations. In 13 of 15 patients the insurance plan required preauthorization, which we obtained in 70% and ultimately achieved reimbursement in 50%. Interoperability enabled assessment of 12 different combinations of modules that underline the importance of an adaptive workflow and policy tailoring to achieve higher yields of reimbursement. The survey confirmed a positive attitude toward self-organizing teams. We acknowledge the individuals and their interactions and termed the infrastructure: human pipeline. Nontechnical barriers currently are limiting the scope and availability of clinical genomic sequencing. The presented human pipeline is one approach toward long-term financial sustainability of clinical genomics. | ||
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of molecular diagnostics |d Amsterdam [u.a.] : Elsevier, 1999 |g 18(2016), 5, Seite 697-706 |h Online-Ressource |w (DE-627)324916922 |w (DE-600)2032654-3 |w (DE-576)309203805 |x 1943-7811 |7 nnas |a Health care infrastructure for financially sustainable clinical genomics |
| 773 | 1 | 8 | |g volume:18 |g year:2016 |g number:5 |g pages:697-706 |g extent:10 |a Health care infrastructure for financially sustainable clinical genomics |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jmoldx.2016.04.003 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1525157816300861 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180213 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 15 | ||
| 999 | |a KXP-PPN1569771324 |e 2998860109 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 13.02.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1569771324","language":["eng"],"person":[{"family":"Lennerz","given":"Jochen K.","display":"Lennerz, Jochen K.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Stenzinger","given":"Albrecht","roleDisplay":"VerfasserIn","display":"Stenzinger, Albrecht","role":"aut"}],"title":[{"title_sort":"Health care infrastructure for financially sustainable clinical genomics","title":"Health care infrastructure for financially sustainable clinical genomics"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"origin":[{"dateIssuedDisp":"1999-","publisher":"Elsevier ; Soc.","dateIssuedKey":"1999","publisherPlace":"Amsterdam [u.a.] ; Bethesda, Md."}],"id":{"issn":["1943-7811"],"eki":["324916922"],"zdb":["2032654-3"]},"name":{"displayForm":["the American Society for Investigative Pathology and the Association for Molecular Pathology"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"The journal of molecular diagnostics","title_sort":"journal of molecular diagnostics"}],"pubHistory":["1.1999,1(Nov.) -"],"titleAlt":[{"title":"JMD online"}],"part":{"year":"2016","pages":"697-706","issue":"5","text":"18(2016), 5, Seite 697-706","volume":"18","extent":"10"},"disp":"Health care infrastructure for financially sustainable clinical genomicsThe journal of molecular diagnostics","note":["Gesehen am 17.01.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"324916922","corporate":[{"display":"American Society for Investigative Pathology","roleDisplay":"Herausgebendes Organ","role":"isb"},{"roleDisplay":"Herausgebendes Organ","display":"Association for Molecular Pathology","role":"isb"}],"language":["eng"]}],"name":{"displayForm":["Jochen K. Lennerz, Heather M. McLaughlin, Jason M. Baron, David Rasmussen, Meini Sumbada Shin, Nancy Berners-Lee, Julie Miller Batten, Kathryn J. Swoboda, Manish K. Gala, Harland S. Winter, Jeremy D. Schmahmann, David A. Sweetser, Marianne Boswell, Maciej Pacula, Albrecht Stenzinger, Long P. Le, William Hynes, Heidi L. Rehm, Anne Klibanski, Stephen W. Black-Schaffer, Jeffrey A. Golden, David N. Louis, Scott T. Weiss, and A. John Iafrate"]},"origin":[{"dateIssuedDisp":"25 July 2016","dateIssuedKey":"2016"}],"id":{"doi":["10.1016/j.jmoldx.2016.04.003"],"eki":["1569771324"]}} | ||
| SRT | |a LENNERZJOCHEALTHCARE2520 | ||